Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss

Completed · Phase 2

Conditions studied: Cachexia, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Megestrol helps improve appetite. Exercise may decrease cancer-related fatigue, improve strength, and build up lost muscle tissue. Exercise plus megestrol may be effective treatment for cancer-related weight loss. PURPOSE: Phase II trial to study the effectiveness of megestrol plus exercise to improve appetite, increase strength, gain lean body tissue, and decrease fatigue in patients who have cancer-related weight loss.

Key facts

Study ID

NCT00004912

Run by

Northwestern University

Starts

2000-01-01

Expected to finish

2003-11-01

Last updated by the study team

2012-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Arkansas - Department of Geriatrics — North Little Rock, Arkansas, United States
• Pacific Shores Medical Group — Long Beach, California, United States
• Shands Hospital and Clinics, University of Florida — Gainesville, Florida, United States
• Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
• Office of David Cella — Evanston, Illinois, United States
• Rex Healthcare — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.